Cytokine Expansion Protocol
Cytokine Expansion Protocol - Related Videos
07:20
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
0 Views •
Cited by 6 •
2011
An efficient protocol for the ex vivo expansion of tumor-reactive T cells from tumor-draining lymph nodes or other secondary lymphoid tissues of tumor-bearing hosts is described. This protocol selectively expands tumor-specific T cells for use in adoptive immunotherapy of breast cancer.
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
0 Views •
Cited by 2 •
2020
Here, we present a protocol to perform the isolation and expansion of peripheral blood mononuclear cells-derived cytokine-induced CD3+CD56+ killer cells and illustrate their cytotoxicity effect against hematological and solid cancer cells by using an in vitro diagnosis flow cytometry system.
12:58
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
0 Views •
Cited by 2 •
2017
Described here is a method for producing exogenous cytokine in patient-derived xenograft (PDX) mice via weekly intraperitoneal injection of a cytokine-transduced stromal cell line. This method broadens the utility of PDX and provides the option for transient or sustained exogenous cytokine delivery in a multitude of PDX models.
09:42
Analysis of Thermal Expansion via Dilatometry
0 Views •
2023
Source: J. Jacob Chavez, Ryan T. Davis, and Taylor D. Sparks, Department of Materials Science and Engineering, The University of Utah, Salt Lake City, UT Thermal expansion is extremely important when considering which materials will be used in systems that experience fluctuations in temperature. A high or low thermal expansion in a material may or may not be desirable, depending on the application. For instance, in a common liquid thermometer, a material with a high thermal expansion would be...
09:30
Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices
0 Views •
2025
This protocol describes a scalable method for the expansion of Adoptive Cell Therapies (ACT) products, namely Chimeric Antigen Receptor (CAR)-T cells and Cytokine-Induced Killer (CIK) cells, using Gas-permeable Rapid expansion (G-Rex) devices, demonstrating efficient and robust growth in a clinically relevant setting.
FAQs
Cytokine receptor signaling can activate JAK-STAT, PI3K-AKT, and MAPK pathways, with each contributing to cellular responses such as survival, proliferation, or differentiation. Because these pathways influence both cell number and functional state, the resulting culture may contain more cells without being functionally identical to the starting population. This distinction matters when interpreting downstream immune assays.
Cytokine concentration and culture duration help determine how strongly cells are stimulated and how long that stimulation continues. These variables can influence the balance between survival, proliferation, and differentiation, thereby shaping the final immune-cell population. Keeping them controlled is important for comparing experiments, because changes in either condition may alter both cell yield and functional characteristics.
The cytokines selected for culture influence which immune cells become enriched and what functional state they acquire. A protocol may therefore produce an enriched T-cell, natural killer cell, or other leukocyte population, rather than simply increasing every cell type equally. This selection is important when the expanded cells must support a specific pathogen-related assay or functional comparison.
A general workflow begins by choosing the immune-cell population and the cytokines appropriate to the experimental objective, then culturing the cells under controlled conditions. Researchers define or maintain the relevant cytokine concentrations and culture duration before using the expanded population for downstream work. These steps connect the intended biological response with a reproducible cell source for later analyses.
Researchers can apply the method when they need sufficient enriched immune cells for pathogen-specific assays, functional characterization, or comparative studies. Expanded T cells, natural killer cells, and other leukocytes may provide a more practical source for examining immune responses to infection. The approach also supports experiments that require standardized cell inputs across multiple conditions or samples.
Standardizing cytokine concentrations, culture duration, and other controlled culture conditions can improve assay consistency and make comparisons more meaningful. It can also generate enough cells for downstream molecular analyses or translational investigations. In immunology and infection research, this consistency helps researchers relate observed differences to the experimental question rather than to uncontrolled variation in cell preparation.